ID   HROG04
AC   CVCL_4U39
DR   cancercelllines; CVCL_4U39
DR   CLS; 300932
DR   Wikidata; Q54895308
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01,02 (Direct_author_submission).
CC   HLA typing: A*01:01:01,05:35; B*08:01,03:01:01; C*07:01:01,15:02:01; DPB1*01:01:01,04:01:01; DQA1*05:01:01,05:05:01; DQB1*02:01:01,03:01:01; DRB1*03:01:01,11:01:01 (CLS=300932).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Trp274Leu (c.821G>T); ClinVar=VCV000427600; Zygosity=Unspecified (CLS=300932).
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
ST   Source(s): CLS=300932
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 18.3,19
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 15,20
ST   D19S433: 14,15.2
ST   D1S1656: 15.3,16
ST   D21S11: 30
ST   D2S1338: 21,23
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D6S1043: 11,12
ST   D7S820: 7,10
ST   D8S1179: 10,13
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 12,18
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7GY ! B-LCL-HROG04
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 16
//
RX   PubMed=23951083; DOI=10.1371/journal.pone.0071070; PMCID=PMC3737284;
RA   Mullins C.S., Schneider B., Stockhammer F., Krohn M., Classen C.F.,
RA   Linnebacher M.;
RT   "Establishment and characterization of primary glioblastoma cell lines
RT   from fresh and frozen material: a detailed comparison.";
RL   PLoS ONE 8:E71070-E71070(2013).
//